TITLE

YOUR DRUG WAS DISCONTINUED

AUTHOR(S)
Weil, Andrew
PUB. DATE
May 2006
SOURCE
Time International (South Pacific Edition);5/8/2006, Issue 18, p139
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents information on issues related to the substitution of animal insulin with the synthetic one. The selling of animal insulin has been terminated in the U.S. from April 1, 2006, and synthetic human insulin, produced by recombinant-DNA technology, have entered the markets. Patients complain that synthetic insulin is not good for their health whereas doctors claim that it is the gold standard for treating Type 1 diabetes.
ACCESSION #
23525739

 

Related Articles

  • insulin aspart.  // Royal Society of Medicine: Medicines;2002, p305 

    The article presents information on insulin aspart, a recombinant biosynthetic human insulin analogue, which is used in diabetic treatment to maintain diabetic patients. Insulin aspart has a faster rate of onset and offset of action than soluble insulin. Administration is by injection.

  • insulin lispro.  // Royal Society of Medicine: Medicines;2002, p305 

    The article presents information on insulin lispro, a recombinant biosynthetic human insulin analogue, which is used in diabetic treatment to maintain diabetic patients. Insulin lispro is relatively short-acting. Administration is by injection.

  • Insulin: A Voice for Choice. Teuscher, Arthur // Diabetes Health;Dec2007/Jan2008, Vol. 16 Issue 6, p18 

    The article discusses the dangers of hypoglycemic unawareness in diabetics who are taking human insulin. Human insulin came into use in the 1980s as a more physiological alternative to animal insulin, but some patients however reported a sudden loss of symptoms that had previously warned them...

  • A Case of Suppurative Granuloma Induced by Insulin Injection. Tanizaki, Hideaki; Matsumura, Vumi; Tokura, Yoshiki; Miyachi, Yoshiki; Kabashim, Kenji // Acta Dermato-Venereologica;2010, Vol. 90 Issue 5, p540 

    The article presents a case study of a 76-year-old woman with diabetes mellitus presenting with multiple deep-seated, slightly pruritic, symmetrical skin nodules on the flanks and thighs. She claimed that the lesion appeared two-three days after insulin injections. A skin biopsy of an...

  • Creating Insulin With a little help from E. coli.  // Time;9/18/1978, Vol. 112 Issue 12, p102 

    The article reports on the success of scientists in California in creating a microbe that can manufacture human-type insulin. The joint effort of two five-man research teams led by biochemist David Goeddell successfully created insulin, which is needed by the body to metabolize sugar and other...

  • Insulin Utopia. Trecroci, Daniel // Diabetes Health;Dec2008/Jan2009, Vol. 17 Issue 6, p7 

    The article discusses the available insulins for every diabetes type. New insulins include a 24-hour insulin called Lantus which was approved in 2001, Levemir approved in 2005, fast-acting insulin called Apidra which was approved in 2004, Humalog, and NovoLog. These insulins were formulated to...

  • An alternative insulin for diabetic dogs. Blake, Avi // Veterinary Medicine;Oct2012, Vol. 107 Issue 10, p430 

    The article discusses alternative insulin for dogs with diabetes mellitus in the U.S. It mentions that some of them suffering from the said disease are insufficiently controlled with neutral protamine Hagedorn (NPH) insulin which led veterinarians to search for a longer-acting insulin...

  • Insulin-producing neurospheres.  // PLoS Medicine;Apr2005, Vol. 2 Issue 4, p269 

    Discusses research being done on the differentiation of insulin-producing cells from human neural progenitor cells. Reference to a study by Seung Kim and colleagues published in this issue; Availability of recombinant insulin; Search for renewable sources of insulin-producing cells through...

  • Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor.  // British Medical Journal;1/27/1979, Vol. 1 Issue 6158, p220 

    Examines the improved metabolic profiles in insulin-treated diabetic patients administered with an alpha-glucosidehydrolase inhibitor. Effect of acarbose on postprandial increases in blood glucose; Reduction of glucose absorption rate; Fermentation of non-absorbed sugars.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics